Clinical Trial Update: Neuroprotective Effect of Neurotropin on Chronic OXA-induced Neurotoxicity in Stage II and Stage III CRC Patients [Phase 3]

View source ↗

Summary

Completed Phase 3 trial evaluating Neurotropin for oxaliplatin-induced neurotoxicity in stage II/III colorectal cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Neurotropin

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED